Vanderbilt Kennedy Center

Treating core Rett syndrome symptoms

A new study published in Neurology reports the drug trofinetide has proven safe and effective in treating core symptoms of Rett syndrome in female children and adolescents.

From left, Deborah Wofford, Janet Shouse and Beth Malow, MD, MS, are among a team of Vanderbilt Kennedy Center researchers seeking to improve access to care for adults with autism.

Kennedy Center program seeks to help community providers treat adults with autism

Researchers at the Vanderbilt Kennedy Center are on a quest to increase health care capacity for adults with autism by bringing quality care into their communities.

Immune ‘pruning’ in schizophrenia

Ariel Deutch and colleagues have discovered that overactive brain immune cells during adolescence may contribute to schizophrenia.

Cancer researcher Kimberly Dahlman is too busy to run in the Boston Marathon, but she’s doing it anyway — for her daughter

“Even though I felt like I was already over-committed, I knew that I needed to do this”

Telemedicine holds promise for quick diagnosis of autism

Although increasing evidence shows that children with autism spectrum disorder (ASD) can be accurately identified during their second year of life, the average age of diagnosis in both Tennessee and across the country remains well above 4 years of age.

Study finds children with autism more likely to face maltreatment

A recent study by Vanderbilt researchers of 11 counties in Middle Tennessee revealed that children with autism spectrum disorder (ASD) were nearly 2.5 times more likely than children without ASD to be reported to the Child Abuse Hotline by the age of 8.

1 2 3 4 5 6 12